Structure

Physi-Chem Properties

Molecular Weight:  280.11
Volume:  305.414
LogP:  3.889
LogD:  3.511
LogS:  -4.401
# Rotatable Bonds:  6
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.492
Synthetic Accessibility Score:  2.393
Fsp3:  0.056
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.738
MDCK Permeability:  1.5097200957825407e-05
Pgp-inhibitor:  0.003
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.894
30% Bioavailability (F30%):  0.722

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.078
Plasma Protein Binding (PPB):  99.5390853881836%
Volume Distribution (VD):  0.455
Pgp-substrate:  0.549679696559906%

ADMET: Metabolism

CYP1A2-inhibitor:  0.959
CYP1A2-substrate:  0.094
CYP2C19-inhibitor:  0.946
CYP2C19-substrate:  0.067
CYP2C9-inhibitor:  0.789
CYP2C9-substrate:  0.959
CYP2D6-inhibitor:  0.781
CYP2D6-substrate:  0.909
CYP3A4-inhibitor:  0.691
CYP3A4-substrate:  0.339

ADMET: Excretion

Clearance (CL):  5.209
Half-life (T1/2):  0.564

ADMET: Toxicity

hERG Blockers:  0.113
Human Hepatotoxicity (H-HT):  0.03
Drug-inuced Liver Injury (DILI):  0.148
AMES Toxicity:  0.616
Rat Oral Acute Toxicity:  0.028
Maximum Recommended Daily Dose:  0.882
Skin Sensitization:  0.952
Carcinogencity:  0.86
Eye Corrosion:  0.005
Eye Irritation:  0.961
Respiratory Toxicity:  0.911

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC87113

Natural Product ID:  NPC87113
Common Name*:   Isostrebluslignanaldehyde
IUPAC Name:   (E)-3-[4-(2-hydroxy-4-prop-2-enylphenoxy)phenyl]prop-2-enal
Synonyms:   isostrebluslignanaldehyde
Standard InCHIKey:  OEMPNLUEIYKHQQ-HWKANZROSA-N
Standard InCHI:  InChI=1S/C18H16O3/c1-2-4-15-8-11-18(17(20)13-15)21-16-9-6-14(7-10-16)5-3-12-19/h2-3,5-13,20H,1,4H2/b5-3+
SMILES:  C=CCc1ccc(c(c1)O)Oc1ccc(/C=C/C=O)cc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2346746
PubChem CID:   71580866
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0004155] Diphenylethers

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28043 Streblus asper Species Moraceae Eukaryota Roots n.a. n.a. PMID[23434030]
NPO28043 Streblus asper Species Moraceae Eukaryota n.a. n.a. n.a. PMID[4093781]
NPO28043 Streblus asper Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Ratio CC50/IC50 = 3.27 n.a. PMID[503801]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 61220.0 nM PMID[503801]
NPT2 Others Unspecified Ratio CC50/IC50 = 19.11 n.a. PMID[503801]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 10490.0 nM PMID[503801]
NPT2 Others Unspecified Ratio CC50/IC50 = 16.46 n.a. PMID[503801]
NPT963 Organism Hepatitis B virus Hepatitis B virus IC50 = 12180.0 nM PMID[503801]
NPT27 Others Unspecified CC50 = 200430.0 nM PMID[503801]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC87113 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9291 High Similarity NPC237594
0.9291 High Similarity NPC249791
0.9291 High Similarity NPC119060
0.9291 High Similarity NPC476387
0.9268 High Similarity NPC213552
0.9268 High Similarity NPC120225
0.9237 High Similarity NPC86947
0.9219 High Similarity NPC214729
0.9213 High Similarity NPC36490
0.9187 High Similarity NPC289459
0.9174 High Similarity NPC290451
0.9174 High Similarity NPC127389
0.9106 High Similarity NPC246704
0.9091 High Similarity NPC189844
0.9091 High Similarity NPC109083
0.9091 High Similarity NPC60962
0.9091 High Similarity NPC224814
0.9091 High Similarity NPC14007
0.9091 High Similarity NPC269843
0.9076 High Similarity NPC39793
0.9048 High Similarity NPC83062
0.8992 High Similarity NPC144662
0.896 High Similarity NPC179777
0.8952 High Similarity NPC20443
0.8952 High Similarity NPC60517
0.8952 High Similarity NPC146886
0.8939 High Similarity NPC267291
0.8898 High Similarity NPC241354
0.8889 High Similarity NPC123228
0.8889 High Similarity NPC151167
0.8889 High Similarity NPC123722
0.8889 High Similarity NPC5018
0.8889 High Similarity NPC276466
0.888 High Similarity NPC194519
0.888 High Similarity NPC3221
0.8872 High Similarity NPC224876
0.8872 High Similarity NPC83375
0.8871 High Similarity NPC229084
0.8871 High Similarity NPC18984
0.8871 High Similarity NPC160900
0.8871 High Similarity NPC106659
0.8855 High Similarity NPC471664
0.8855 High Similarity NPC471665
0.8843 High Similarity NPC470626
0.8843 High Similarity NPC212743
0.8819 High Similarity NPC110313
0.8819 High Similarity NPC226661
0.881 High Similarity NPC303680
0.881 High Similarity NPC178284
0.881 High Similarity NPC191037
0.881 High Similarity NPC90128
0.881 High Similarity NPC58607
0.881 High Similarity NPC84076
0.8806 High Similarity NPC278469
0.8806 High Similarity NPC193722
0.88 High Similarity NPC114901
0.88 High Similarity NPC293701
0.88 High Similarity NPC48990
0.8788 High Similarity NPC126206
0.878 High Similarity NPC207613
0.878 High Similarity NPC204466
0.877 High Similarity NPC281298
0.877 High Similarity NPC263386
0.877 High Similarity NPC310338
0.877 High Similarity NPC141791
0.876 High Similarity NPC293619
0.876 High Similarity NPC280001
0.875 High Similarity NPC304622
0.874 High Similarity NPC111247
0.874 High Similarity NPC41706
0.874 High Similarity NPC183181
0.874 High Similarity NPC163332
0.874 High Similarity NPC292056
0.874 High Similarity NPC319625
0.874 High Similarity NPC118787
0.874 High Similarity NPC147821
0.872 High Similarity NPC317769
0.872 High Similarity NPC31344
0.872 High Similarity NPC242372
0.872 High Similarity NPC257976
0.872 High Similarity NPC4181
0.872 High Similarity NPC164778
0.871 High Similarity NPC324571
0.871 High Similarity NPC54872
0.871 High Similarity NPC70752
0.871 High Similarity NPC470212
0.871 High Similarity NPC312675
0.871 High Similarity NPC473853
0.871 High Similarity NPC113865
0.871 High Similarity NPC262156
0.871 High Similarity NPC184651
0.871 High Similarity NPC343720
0.8702 High Similarity NPC135127
0.8699 High Similarity NPC165133
0.8699 High Similarity NPC232316
0.8699 High Similarity NPC242885
0.8699 High Similarity NPC56214
0.8699 High Similarity NPC227217
0.8699 High Similarity NPC95614
0.8699 High Similarity NPC117780
0.8699 High Similarity NPC202474
0.8689 High Similarity NPC275519
0.8676 High Similarity NPC474444
0.8676 High Similarity NPC264706
0.8676 High Similarity NPC93433
0.8676 High Similarity NPC284881
0.8672 High Similarity NPC478215
0.8672 High Similarity NPC72529
0.8661 High Similarity NPC17837
0.8661 High Similarity NPC276014
0.8661 High Similarity NPC304630
0.8651 High Similarity NPC228972
0.8651 High Similarity NPC312404
0.8651 High Similarity NPC74478
0.8651 High Similarity NPC122792
0.8651 High Similarity NPC273686
0.8651 High Similarity NPC109822
0.8651 High Similarity NPC94276
0.864 High Similarity NPC71090
0.864 High Similarity NPC85488
0.864 High Similarity NPC114298
0.864 High Similarity NPC286573
0.8629 High Similarity NPC470848
0.8629 High Similarity NPC470849
0.8618 High Similarity NPC37858
0.8607 High Similarity NPC164386
0.8605 High Similarity NPC86030
0.8605 High Similarity NPC5851
0.8594 High Similarity NPC210355
0.8583 High Similarity NPC53305
0.8583 High Similarity NPC257589
0.8571 High Similarity NPC280704
0.8571 High Similarity NPC90431
0.8571 High Similarity NPC173746
0.8571 High Similarity NPC120852
0.8571 High Similarity NPC156840
0.8571 High Similarity NPC8547
0.8571 High Similarity NPC471693
0.8571 High Similarity NPC257124
0.8561 High Similarity NPC111635
0.856 High Similarity NPC147654
0.856 High Similarity NPC38996
0.856 High Similarity NPC160380
0.8551 High Similarity NPC287495
0.8551 High Similarity NPC9370
0.8548 High Similarity NPC2058
0.8538 High Similarity NPC472338
0.8538 High Similarity NPC298268
0.8537 High Similarity NPC70744
0.8537 High Similarity NPC272471
0.8537 High Similarity NPC107588
0.8537 High Similarity NPC277460
0.8537 High Similarity NPC137537
0.8537 High Similarity NPC164706
0.8516 High Similarity NPC127937
0.8516 High Similarity NPC92207
0.8516 High Similarity NPC134431
0.8516 High Similarity NPC156854
0.85 High Similarity NPC165646
0.8496 Intermediate Similarity NPC204592
0.8487 Intermediate Similarity NPC179309
0.848 Intermediate Similarity NPC307253
0.848 Intermediate Similarity NPC158949
0.8473 Intermediate Similarity NPC472597
0.8468 Intermediate Similarity NPC24474
0.8468 Intermediate Similarity NPC311595
0.8456 Intermediate Similarity NPC82336
0.8456 Intermediate Similarity NPC78987
0.845 Intermediate Similarity NPC470699
0.8444 Intermediate Similarity NPC284409
0.8438 Intermediate Similarity NPC280767
0.8438 Intermediate Similarity NPC271985
0.8438 Intermediate Similarity NPC148627
0.8429 Intermediate Similarity NPC473408
0.8429 Intermediate Similarity NPC236166
0.8421 Intermediate Similarity NPC473054
0.8417 Intermediate Similarity NPC78918
0.8417 Intermediate Similarity NPC55300
0.8417 Intermediate Similarity NPC139617
0.8417 Intermediate Similarity NPC297657
0.8413 Intermediate Similarity NPC201777
0.8409 Intermediate Similarity NPC470752
0.8409 Intermediate Similarity NPC16208
0.8409 Intermediate Similarity NPC245120
0.8409 Intermediate Similarity NPC2190
0.8409 Intermediate Similarity NPC7903
0.8409 Intermediate Similarity NPC35932
0.8409 Intermediate Similarity NPC160991
0.8409 Intermediate Similarity NPC184447
0.8406 Intermediate Similarity NPC160378
0.8403 Intermediate Similarity NPC36108
0.8403 Intermediate Similarity NPC233731
0.8403 Intermediate Similarity NPC7097
0.8403 Intermediate Similarity NPC246358
0.8397 Intermediate Similarity NPC172673
0.8397 Intermediate Similarity NPC244246
0.8397 Intermediate Similarity NPC65935
0.8397 Intermediate Similarity NPC137427
0.8397 Intermediate Similarity NPC66905
0.8397 Intermediate Similarity NPC91291

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC87113 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8871 High Similarity NPD4379 Clinical (unspecified phase)
0.8571 High Similarity NPD228 Approved
0.8308 Intermediate Similarity NPD9494 Approved
0.8306 Intermediate Similarity NPD5536 Phase 2
0.8182 Intermediate Similarity NPD3027 Phase 3
0.813 Intermediate Similarity NPD5283 Phase 1
0.8017 Intermediate Similarity NPD2684 Approved
0.8 Intermediate Similarity NPD4060 Phase 1
0.8 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD1613 Approved
0.797 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7868 Intermediate Similarity NPD1558 Phase 1
0.7851 Intermediate Similarity NPD968 Approved
0.7805 Intermediate Similarity NPD3022 Approved
0.7805 Intermediate Similarity NPD3021 Approved
0.776 Intermediate Similarity NPD7843 Approved
0.7737 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD3620 Phase 2
0.7733 Intermediate Similarity NPD3882 Suspended
0.7717 Intermediate Similarity NPD7157 Approved
0.7704 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD5846 Approved
0.7692 Intermediate Similarity NPD6516 Phase 2
0.7687 Intermediate Similarity NPD6584 Phase 3
0.766 Intermediate Similarity NPD7266 Discontinued
0.7651 Intermediate Similarity NPD1934 Approved
0.7647 Intermediate Similarity NPD7095 Approved
0.7642 Intermediate Similarity NPD1358 Approved
0.7634 Intermediate Similarity NPD3496 Discontinued
0.763 Intermediate Similarity NPD2861 Phase 2
0.7619 Intermediate Similarity NPD1653 Approved
0.7615 Intermediate Similarity NPD1357 Approved
0.76 Intermediate Similarity NPD2801 Approved
0.7578 Intermediate Similarity NPD6671 Approved
0.7561 Intermediate Similarity NPD3134 Approved
0.7559 Intermediate Similarity NPD1241 Discontinued
0.7554 Intermediate Similarity NPD4340 Discontinued
0.7538 Intermediate Similarity NPD1548 Phase 1
0.7538 Intermediate Similarity NPD1894 Discontinued
0.7536 Intermediate Similarity NPD2674 Phase 3
0.75 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD290 Approved
0.75 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4110 Phase 3
0.75 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.748 Intermediate Similarity NPD5535 Approved
0.7466 Intermediate Similarity NPD1511 Approved
0.7466 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD6798 Discontinued
0.7463 Intermediate Similarity NPD6582 Phase 2
0.7463 Intermediate Similarity NPD6583 Phase 3
0.7444 Intermediate Similarity NPD1610 Phase 2
0.7431 Intermediate Similarity NPD4162 Approved
0.7429 Intermediate Similarity NPD6355 Discontinued
0.7424 Intermediate Similarity NPD4626 Approved
0.741 Intermediate Similarity NPD6233 Phase 2
0.741 Intermediate Similarity NPD4062 Phase 3
0.7388 Intermediate Similarity NPD2231 Phase 2
0.7388 Intermediate Similarity NPD2235 Phase 2
0.7379 Intermediate Similarity NPD6331 Phase 2
0.7365 Intermediate Similarity NPD1512 Approved
0.7348 Intermediate Similarity NPD5691 Approved
0.7348 Intermediate Similarity NPD5585 Approved
0.7344 Intermediate Similarity NPD821 Approved
0.7338 Intermediate Similarity NPD3144 Approved
0.7338 Intermediate Similarity NPD3145 Approved
0.7333 Intermediate Similarity NPD2982 Phase 2
0.7333 Intermediate Similarity NPD2983 Phase 2
0.7333 Intermediate Similarity NPD3866 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD6190 Approved
0.7319 Intermediate Similarity NPD4908 Phase 1
0.7313 Intermediate Similarity NPD1535 Discovery
0.7313 Intermediate Similarity NPD422 Phase 1
0.7313 Intermediate Similarity NPD3705 Approved
0.7311 Intermediate Similarity NPD2933 Approved
0.7311 Intermediate Similarity NPD2934 Approved
0.7311 Intermediate Similarity NPD9296 Approved
0.731 Intermediate Similarity NPD3060 Approved
0.7305 Intermediate Similarity NPD447 Suspended
0.7296 Intermediate Similarity NPD3818 Discontinued
0.7286 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6166 Phase 2
0.7273 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD1182 Approved
0.726 Intermediate Similarity NPD8166 Discontinued
0.7259 Intermediate Similarity NPD1481 Phase 2
0.7259 Intermediate Similarity NPD2981 Phase 2
0.725 Intermediate Similarity NPD2860 Approved
0.725 Intermediate Similarity NPD2859 Approved
0.7246 Intermediate Similarity NPD3018 Phase 2
0.7236 Intermediate Similarity NPD291 Approved
0.7234 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD4140 Approved
0.723 Intermediate Similarity NPD4357 Discontinued
0.7226 Intermediate Similarity NPD2797 Approved
0.7222 Intermediate Similarity NPD2161 Phase 2
0.7222 Intermediate Similarity NPD2935 Discontinued
0.7219 Intermediate Similarity NPD3455 Phase 2
0.7214 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD3020 Approved
0.7208 Intermediate Similarity NPD3817 Phase 2
0.72 Intermediate Similarity NPD9697 Approved
0.7183 Intermediate Similarity NPD5735 Approved
0.7181 Intermediate Similarity NPD4123 Phase 3
0.7164 Intermediate Similarity NPD1778 Approved
0.7143 Intermediate Similarity NPD5163 Phase 2
0.7143 Intermediate Similarity NPD7054 Approved
0.7133 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD6653 Approved
0.7132 Intermediate Similarity NPD1840 Phase 2
0.7132 Intermediate Similarity NPD1608 Approved
0.7123 Intermediate Similarity NPD5958 Discontinued
0.7123 Intermediate Similarity NPD2424 Discontinued
0.7123 Intermediate Similarity NPD4534 Discontinued
0.7123 Intermediate Similarity NPD7153 Discontinued
0.7121 Intermediate Similarity NPD3596 Phase 2
0.7111 Intermediate Similarity NPD3847 Discontinued
0.7109 Intermediate Similarity NPD5451 Approved
0.7103 Intermediate Similarity NPD6032 Approved
0.7103 Intermediate Similarity NPD1551 Phase 2
0.7101 Intermediate Similarity NPD1203 Approved
0.7099 Intermediate Similarity NPD7472 Approved
0.7099 Intermediate Similarity NPD7074 Phase 3
0.7095 Intermediate Similarity NPD5241 Discontinued
0.7092 Intermediate Similarity NPD5109 Approved
0.7092 Intermediate Similarity NPD5110 Phase 2
0.7092 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD5111 Phase 2
0.7092 Intermediate Similarity NPD5718 Phase 2
0.709 Intermediate Similarity NPD1651 Approved
0.7083 Intermediate Similarity NPD4536 Approved
0.7083 Intermediate Similarity NPD4538 Approved
0.7083 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD4359 Approved
0.708 Intermediate Similarity NPD5327 Phase 3
0.7075 Intermediate Similarity NPD4236 Phase 3
0.7075 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD4237 Approved
0.7067 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD230 Phase 1
0.7063 Intermediate Similarity NPD1933 Approved
0.7059 Intermediate Similarity NPD9365 Approved
0.7059 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1091 Approved
0.7055 Intermediate Similarity NPD2344 Approved
0.7055 Intermediate Similarity NPD5763 Approved
0.7055 Intermediate Similarity NPD5762 Approved
0.7055 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD3686 Approved
0.7039 Intermediate Similarity NPD3687 Approved
0.7037 Intermediate Similarity NPD2423 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD5960 Phase 3
0.7034 Intermediate Similarity NPD2799 Discontinued
0.7034 Intermediate Similarity NPD5588 Approved
0.7032 Intermediate Similarity NPD1465 Phase 2
0.7029 Intermediate Similarity NPD1283 Approved
0.7029 Intermediate Similarity NPD8651 Approved
0.7029 Intermediate Similarity NPD2922 Phase 1
0.7029 Intermediate Similarity NPD3225 Approved
0.7027 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD4625 Phase 3
0.702 Intermediate Similarity NPD6273 Approved
0.7015 Intermediate Similarity NPD6580 Approved
0.7015 Intermediate Similarity NPD6581 Approved
0.7014 Intermediate Similarity NPD2653 Approved
0.7014 Intermediate Similarity NPD2492 Phase 1
0.7007 Intermediate Similarity NPD1549 Phase 2
0.7007 Intermediate Similarity NPD3972 Approved
0.7007 Intermediate Similarity NPD7037 Approved
0.7 Intermediate Similarity NPD6799 Approved
0.6993 Remote Similarity NPD3111 Phase 1
0.6986 Remote Similarity NPD1501 Clinical (unspecified phase)
0.6981 Remote Similarity NPD8127 Discontinued
0.6978 Remote Similarity NPD987 Approved
0.6972 Remote Similarity NPD3268 Approved
0.697 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6966 Remote Similarity NPD7097 Phase 1
0.6963 Remote Similarity NPD6830 Clinical (unspecified phase)
0.6962 Remote Similarity NPD6234 Discontinued
0.6959 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6674 Discontinued
0.6959 Remote Similarity NPD5177 Phase 3
0.6957 Remote Similarity NPD4749 Approved
0.6954 Remote Similarity NPD3536 Discontinued
0.6951 Remote Similarity NPD6797 Phase 2
0.6951 Remote Similarity NPD7993 Clinical (unspecified phase)
0.695 Remote Similarity NPD2614 Approved
0.695 Remote Similarity NPD6832 Phase 2
0.6948 Remote Similarity NPD4678 Approved
0.6948 Remote Similarity NPD4380 Phase 2
0.6948 Remote Similarity NPD4675 Approved
0.6947 Remote Similarity NPD9377 Approved
0.6947 Remote Similarity NPD9379 Approved
0.6939 Remote Similarity NPD1552 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data